Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0038187 (
starvation
)
24,951
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We previously identified and characterized a murine BTB domain-containing protein,
CIBZ
(ZBTB38 in human), that interacts with CtBP and binds to methylated CpGs. However, its physiological function remained unknown. As CtBP is reportedly involved in p53-independent programmed cell death, we examine here whether
CIBZ
is associated with apoptosis. We found that
CIBZ
was highly expressed in proliferating C2C12 cells but that its expression levels decreased upon induction of apoptosis by serum
starvation
. Knockdown of
CIBZ
by small interfering RNA in C2C12 cells induced apoptosis, as determined by an increase of annexin V/propidium iodide labeling, activation of caspase-3, and cleavage of poly(ADP-ribose) polymerase.
CIBZ
inhibition also activated caspase-7 and caspase-9, suggesting that
CIBZ
-associated apoptosis occurs through the mitochondrial pathway. Notably, knockdown of
CIBZ
in p53(-/-) mouse embryonic fibroblast cells also activated caspase-3 and cleavage of poly(ADP-ribose) polymerase, indicating that
CIBZ
-associated apoptosis is mediated by a p53-independent pathway; however, because both common and distinct targets are regulated by
CIBZ
- and CtBP-associated apoptosis, we conclude that more than one pathway is involved. Finally, using mutagenesis and an in vitro caspase cleavage assay, we show that
CIBZ
is a novel substrate of caspase-3 and identify two caspase-3 recognition sites. These findings indicate, collectively, that
CIBZ
plays an important role by participating in the negative regulation of apoptosis in murine cells.
...
PMID:Down-regulation of CIBZ, a novel substrate of caspase-3, induces apoptosis. 1837 81